Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep605 | Endocrine tumours and neoplasia | ECE2016

Real life data on Lanreotide Autogel in the treatment of patients with neuroendocrine tumors (NET) – an interim analysis from SOPRANo study

Rinke Anja , Muller Lothar , Maintz Christoph , Bolling Claus , Raderer Markus , Christ-Crain Mirjam , Hoffmanns Philipp , Chevts Vitali , Houchard Aude , Petersenn Stephan

Introduction: This non-interventional study assesses real-life use and potential predictive parameters for lanreotide (LAN) in pts with either acromegaly (ACRO) or NET over a period of 24 months. We present a pre-specified interim analysis after first 6 months of therapy.Methods: The primary objective is to evaluate the long term treatment response under LAN and to correlate it with early changes of biochemical markers. The planned sample size is 152 (76...